Evidence map›Paper›PMID 23114888›Full record

ReviewJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2012

Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders.

Lena Al-Harthi

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. The Molecular Basis of Wnt/International journal of cell biology · 2023
    Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Lena Al-Harthi
Rush University Medical Center · US

Funding

Tissue Culture and Virology Laboratory CoreP01AI082971 · NIAID · RUSH UNIVERSITY MEDICAL CENTER · PI LANDAY, ALAN L · 2009 to 2013
$11.2M
Interplay between neuroprotective pathways, HIV, and astrocytesR01NS060632 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI AL-HARTHI, LENA · 2008 to 2018
$4.9M
mechanisms of HIV and drug abuse pathogenesis in CNSR01DA033966 · NIDA · RUSH UNIVERSITY MEDICAL CENTER · PI AL-HARTHI, LENA · 2012 to 2016
$1.7M
Protective pathways against Meth abuse and HIV neuropathogenesisR03DA026723 · NIDA · RUSH UNIVERSITY MEDICAL CENTER · PI AL-HARTHI, LENA · 2010 to 2011
$296k
NIAID NIH HHS P01 AI082971NIDA NIH HHS R01 DA 033966NIDA NIH HHS R01 DA033966NIDA NIH HHS R03 DA 026723NIDA NIH HHS R03 DA026723NINDS NIH HHS R01 NS060632PHS HHS P01A1082971
6 · The paper itself

Abstract

Wnt signaling is a fundamental pathway in embryogenesis which is evolutionary conserved from metazoans to humans. Much of our understanding of Wnt signaling events emerged from key developmental studies in drosophila, zebra fish, xenopus, and mice. Considerable data now exists on the role of Wnt signaling beyond these developmental processes and in particular its role in health and disease. The focus of this special issue is on Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders. This special issue is composed of six reviews and two original articles selected to highlight recent advances in the role of Wnt signaling in CNS embryonic development, in adult brain function, in neurodegenerative conditions such as Alzheimer's disease, schizophrenia, NeuroAIDS, and in gliomas. The finding that β-catenin can translocate to the nucleus where it binds to TCF/LEF transcription factors to regulate target gene expression was a seminal observation that linked β-catenin/LEF to T cell development and differentiation. We also provide a nostalgic look on recent advances in role of Wnts in T cell development and maturation. These reviews highlight the extensive body of work in these thematic areas as well as identify knowledge gaps, where appropriate. Understanding Wnt function under healthy and diseased conditions may provide a therapeutic resource, albeit it a challenging one, in diseases where dysfunctional and/or diminished Wnt signaling is a prominent player in the disease process.

Indexed as

Alzheimer DiseaseAnimalsBehaviorbeta CateninBrain NeoplasmsGliomaHIV InfectionsHumansMental DisordersNervous System DiseasesNeurodegenerative DiseasesSchizophreniaSignal TransductionWnt Signaling Pathwaybeta Catenin

Identifiers

PMID23114888
PMCPMC3690588
OpenAlexW2046679238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.